Therefore, in asymptomatic patients with PSA values of 2–10 ng/mL, additional methods should be used to decide whether to refer the patient for a prostate biopsy, the result of which determines the treatment when cancer is diagnosed. This evidence concerns the gene KLK3 and cancer.